Concentra Group Holdings Parent IncCON
Price$34.97Intrinsic value$28.9217% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.3B+20.4% YoYTTM through 30 Jun 2026
Net Income $198.7M+19.3% YoYTTM through 30 Jun 2026
Free Cash Flow $267.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin29.9%
EBITDA Margin19.9%
Operating Margin16.8%
Net Margin8.7%

Returns

46.0%ROE
6.4%ROA
10.6%ROIC

Balance Sheet Health

Debt / Equity3.93x
Current Ratio1.26x
Net Debt$1.5B
Cash & Equivalents$158M

Quality Metrics

Altman Z-Score2.41
Piotroski F-Score6 / 9
FCF Margin11.7%
Rule of 4014.5
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'22'23'24'25
FY2025: $2.2B
Diluted EPS$1.55TTM
'22'23'24'25
FY2025: $1.30

Dividend

$0.13Per share, FY20260.89%Yield

Capital Allocation

Capex Intensity3.0%

Segment Performance

SegmentRevenueYoYOutlook
Occupational Health Centers
View details

Focus on de novo center openings and organic visit growth

Onsite Health Clinics
View details

Expansion through integrations of acquisitions like Pivot Onsite Innovations

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.